Bevacizumab and irinotecan for recurrent oligodendroglial tumors.
Taillibert S, Vincent LA, Granger B, Marie Y, Carpentier C, Guillevin R, Bellanger A, Mokhtari K, Rousseau A, Psimaras D, Dehais C, Sierra del Rio M, Meng Y, Laigle-Donadey F, Hoang-Xuan K, Sanson M, Delattre JY.
Taillibert S, et al. Among authors: sierra del rio m.
Neurology. 2009 May 5;72(18):1601-6. doi: 10.1212/WNL.0b013e3181a413be.
Neurology. 2009.
PMID: 19414728